Gene Logic, Inc.
15Patents
0Active
15Granted
32Portfolio score
Filing activity: Mar 28, 1997 → Aug 6, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6974667B2 | Gene expression profiles in liver cancer | Emerging Cross-Sectional Technologies | 102 | Expired |
| US6312906A | Immobilized nucleic acid hybridization reagent and method | Chemistry; Metallurgy | 62 | Expired |
| US6365352B1 | Process to study changes in gene expression in granulocytic cells | Chemistry; Metallurgy | 44 | Expired |
| US7251642B1 | Analysis engine and work space manager for use with gene expression data | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6109776A | Method and system for computationally identifying clusters within a set of sequences | Physics | 16 | Expired |
| US7020561B1 | Methods and systems for efficient comparison, identification, processing, and importing of gene expression data | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6048689A | Method for identifying variations in polynucleotide sequences | Chemistry; Metallurgy | 7 | Expired |
| US6931396B1 | Biological data processing | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7031843B1 | Computer methods and systems for displaying information relating to gene expression data | Physics | 6 | Expired |
| US6951721B2 | Method for determining the haplotype of a human BRCA1 gene | Chemistry; Metallurgy | 4 | Expired |
| US6130322A | Coding sequences of the human BRCA1 gene | Chemistry; Metallurgy | 3 | Expired |
| US7321830B2 | Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6838256B2 | Coding sequences of the human BRCA1 gene | Chemistry; Metallurgy | 0 | Expired |
| US6492109B1 | Susceptibility mutation 6495delGC of BRCA2 | Chemistry; Metallurgy | 0 | Expired |
| US6686163B2 | Coding sequence haplotype of the human BRCA1 gene | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.